Study Stopped
The production of the device used in this study has been suspended.
Comparison of Externally Versus Internally Cooled Tip Catheter Ablation in Paroxysmal Atrial Fibrillation
CATAFABL
1 other identifier
interventional
86
1 country
2
Brief Summary
There is no study comparing safety/efficacy of externally vs internally cooled tip catheters in patients undergoing ablation for paroxysmal atrial fibrillation (pAF). The primary objective is to compare safety and efficacy of externally irrigated-tip catheter versus internally irrigated-tip catheter in achieving long term electrical isolation (EI) of pulmonary veins (PV) in paroxysmalatrial fibrillation (pAF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable atrial-fibrillation
Started Dec 2008
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 30, 2008
CompletedFirst Posted
Study publicly available on registry
December 31, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJuly 27, 2012
July 1, 2012
2.2 years
December 30, 2008
July 26, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
RF duration (in minutes) to succeed in PVs isolation
Along intervention
Secondary Outcomes (2)
The absence of pAF
at 3 and 6 months off AAD
The determination of serious adverse events (Complications resulting from vascular access will not be included in this category).
During 6 months
Study Arms (2)
1
ACTIVE COMPARATORThe externally irrigated-tip catheter is an "open system" in which saline is continuously infused and empties into the blood pool. For the externally irrigated-tip catheter, RF energy delivery settings were: power ≤ 35 watts and temperature ≤ 43°C with a variable flow-rate to obtain a temperature around 40°C.
2
EXPERIMENTALFor the internally irrigated tip catheter (reference catheter), radiofrequency (RF) energy delivery settings will be: power ≤ 35 watts, temperature ≤ 47◦C and a fixed flow rate of 0.6 ml/s. The advantage of the Chili thermo-cooled tip system is that no saline solution leaves the catheter system and flows into the patient.
Interventions
All AAD except amiodarone will be stopped five half-lives before the procedure. Our ablation protocol will require 3 catheters. A quadripolar stearable mapping catheter was inserted into the coronary sinus, a decapolar circular mapping catheter was placed at the antrum of the PV after transeptal puncture to help for electrical disconnection of all four PV with the randomized ablation catheter. After transseptal access, an intravenous bolus of heparin was administered and repeated 3 to 4 hours later. Atrial burst will then be used to induce AF. With the ablation catheter positioned proximal to Lasso catheter on the atrial aspect of PV ostium, isolation will be performed.
Eligibility Criteria
You may qualify if:
- Adults (≥18 years old)
- Drug refractory paroxysmal AF with episods lasting \<24hours
- Follow-up possible at one of the 2 institutions performing the study
- Oral agreement of the patient after reading the document of information
You may not qualify if:
- Pregnancy
- Psychiatric troubles not stabilized
- Contraindication to undergo AF ablation
- Previous attempt at AF ablation
- Cardioversion for AF
- No oral agreement of the patient for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Bordeauxlead
- Boston Scientific Corporationcollaborator
Study Sites (2)
University Hospital
Bordeaux, 33064, France
Clinique Pasteur
Toulouse, 31076, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michel HAÏSSAGUERRE, Pr
University Hospital, Bordeaux
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2008
First Posted
December 31, 2008
Study Start
December 1, 2008
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
July 27, 2012
Record last verified: 2012-07